SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-041576
Filing Date
2021-08-05
Accepted
2021-08-05 16:06:16
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 Q2 8-K aveo-8k_20210805.htm   iXBRL 8-K 41673
2 EX-99.1 aveo-ex991_6.htm EX-99.1 291261
3 GRAPHIC gx4n1s1tsogj000001.jpg GRAPHIC 4922
  Complete submission text file 0001564590-21-041576.txt   486249

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210805.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210805_lab.xml EX-101.LAB 18571
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210805_pre.xml EX-101.PRE 11047
7 EXTRACTED XBRL INSTANCE DOCUMENT aveo-8k_20210805_htm.xml XML 3405
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 211148137
SIC: 2834 Pharmaceutical Preparations